for Veterans and the Public
Intelence (etravirine)
- Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
- Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."
Approved adult dosing
200 mg (one 200 mg tablet), twice a day after meals
Morning
200 mg
Evening
200 mg
Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.
200 mg (two 100 mg tablets), twice a day after meals
Morning
100 mg
Evening
100 mg
Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.
Notes on taking this medication
- Take after a meal (do not take without food)
- May dissolve in water and drink immediately. Rinse glass and drink the remainder.
- Intelence can interact with other drugs; consult your medical provider
Side effects
- Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
- Nausea
- Intelence has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug
See accompanying chart: Tips for Common Side Effects
My doctor's instructions
Disclaimer: This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist.
Share this page